Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.36 USD | -2.19% | +12.37% | +27.01% |
08/05 | Transcript : Vanda Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.01% | 319M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals Shares Soar After FDA Approval for Bipolar I Disorder Therapy